Lindsay A. Rosenwald MD - 21 Jul 2022 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
Director
Signature
/s/ Ramsey Alloush, attorney-in-fact
Issuer symbol
DERM
Transactions as of
21 Jul 2022
Net transactions value
$0
Form type
4
Filing time
25 Jul 2022, 09:40:22 UTC
Previous filing
24 Jun 2022
Next filing
24 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, par value $0.0001 per share Award $0 +14,245 $0.000000 14,245 21 Jul 2022 Direct F1, F2
holding DERM Common Stock, par value $0.0001 per share 176,470 21 Jul 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023.
F2 Includes 14,245 restricted stock units, which will vest as set forth in footnote 1.
F3 The shares are held by a limited liability company which the reporting person, as managing member, is deemed to have voting and investment power.